Phcog.Net logo
Submit

BROWSE ALL JOURNALS

    SEE ALL 6 JOURNALS
    Pharmacognosy MagazineNOW IN
    Article

    Effects of Hypericum perforatum extract on rat irritable bowel syndrome

    Shilan Mozaffari2,3★, Hadi Esmaily4, Roja Rahimi3, Maryam Baeeri3, Yara Sanei2,3, Azar Asadi-Shahmirzadi2,3, Mohammad-Hossein Salehi-Surmaghi2,3, Mohammad Abdollahi2,3★ Corresponding author

    1. 1Department of Toxicology and Pharmacology, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran.
    2. 2Pharmaceutical Sciences Research Center, Tehran University of Medical Sciences, Tehran, Iran.
    3. 3Department of Clinical Pharmacy, Faculty of Pharmacy, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

    CORRESPONDENCE

    Shilan Mozaffari

    Pharmaceutical Sciences Research Center, Tehran University of Medical Sciences, Tehran, Iran.

    Received: 04-09-2010; Revised: 16-03-2011.

    Volume 7, Issue 27 · pp. 213–223 · PUBLISHED 25 August 2011 · DOI: 10.4103/0973-1296.84235

    View on Pharmacogn. Mag. original site ↗

    ABSTRACT

    Context: In irritable bowel syndrome (IBS), disturbance of bowel motility is associated with infiltration of inflammatory mediators and cytokines into the intestine, such as neutrophils, myeloperoxidase (MPO), tumor necrosis factor alfa (TNF-α), and lipid peroxide. Aims: Regarding promising anti-inflammatory and anti-oxidative effects of Hypericum perforatum (HP) extract, besides its anti-depressant effect, this study was designed to evaluate the effects of HP in an experimental model of IBS. Settings and Design: IBS was induced by a 5-day restraint stress in rats. The HP extract was administered by gavage in doses of 150, 300, and 450 mg/kg for 26 days. Fluoxetine and loperamide were used as positive controls. Gastric emptying and small bowel and colon transit, besides the levels of TNF-α, MPO, lipid peroxidation, and antioxidant power, were determined in colon homogenates. Statistical Analysis Used: Data were analyzed by one- way ANOVA followed by Tukey’s post hoc test for multiple comparisons. Results: A significant reduction in small bowel and colonic transit (450 mg/kg), TNF-α, MPO, and lipid peroxidation and an increase in antioxidant power in all HP-treated groups (150, 300, and 450 mg/kg) were seen as compared with the control group. Gastric emptying did not alter significantly when compared with the control group. Treatment with loperamide (10 mg/kg) significantly inhibited gastric emptying and small bowel and colonic transit, while flouxetine (10 mg/kg) decreased gastric emptying, TNF-α, MPO, and lipid peroxidation and increased the antioxidant power of the samples in comparison with the control group. Conclusions: HP diminished the recruitment of inflammatory cells and TNF-α following restraint stress not in a dose-dependent manner, possibly via inhibition of MPO activity and increasing colon antioxidant power, without any difference with fluoxetine. The HP extract inhibits small bowel and colonic transit acceleration like loperamide but has minimal effect on gastric emptying.

    KEYWORDS

    Open in new tab

    REFERENCES

    As published

    Showing references and in-text citations exactly as published.

      Cite this article

      SELECT FORMAT

      Mozaffari, S., Esmaily, H., Rahimi, R., Baeeri, M., Sanei, Y., Asadi-Shahmirzadi, A., Salehi-Surmaghi, M., & Abdollahi, M. (2011). Effects of Hypericum perforatum extract on rat irritable bowel syndrome. Pharmacognosy Magazine, 7(27), 213–223. https://doi.org/10.4103/0973-1296.84235